News And Announcements
Trafalgar Property exercises options over land in Surrey
Residential property developer Trafalgar Property Group has exercised its options over land in Barnett Wood Lane, Ashtead, Surrey, it announced on Monday.
Hutchison Chi-Med upbeat on progress with surufatinib
Hutchison China MediTech, trading as Chi-Med, announced on Friday that the independent data monitoring committee of the phase 3 pivotal study of surufatinib in advanced neuroendocrine tumours - pancreatic (SANET-p) has completed a pre-planned interim analysis.
M&C Saatchi FY net cash seen ‘substantially’ ahead of expectations
M&C Saatchi said on Monday that full-year net cash will be "substantially ahead" of expectations, while pre-tax profit will be in line.
Egdon Resources extends deadline for farm-out deal
Egdon Resources updated the market on the exclusivity agreement over licences P1929 and P2304 with a “large, internationally recognised” exploration and production company on Monday, which it previously announced on 4 November.
Tekcapital portfolio firm Lucyd launches new smart glasses
Intellectual property investment company Tekcapital announced on Monday that its portfolio company Lucyd, the smartglass developer and operator of an e-shop for tech eyewear, was launching its third line of ‘Lucyd Loud Bluetooth’ glasses on 27 January.
Aptitude Software shares fall as new CEO takes reins
Financial management software provider Aptitude Software updated the market on the year ended 31 December on Monday, reporting that it made “good progress” in 2019, and expected to report results in line with the board's expectations.
ADES International extends contract for Admarine 261 rig
Oil and gas drilling and production services provider ADES International has extended the contract for Admarine 261 in Saudi Arabia, it announced on Monday.
Zenith Energy announces issue of euro medium term notes
Oil and gas production company Zenith Energy announced the upcoming issue of unsecured, multi-currency euro medium term notes at par value on Monday.
Intu Properties confirms it's looking to raise cash
Shopping centre owner Intu Properties confirmed on Monday that it is looking to raise extra cash to bolster its balance sheet.
Lamprell secures $350m drilling rig contract
Oil rig manufacturer Lamprell has been formally awarded a $350m (£269. 50m) contract to make and deliver two jack-up drilling units with International Maritime Industries (IMI).
Anglo American to buy Sirius Minerals in £404.9m deal
Anglo American has agreed to buy Sirius Minerals for 5. 5p a share in cash, in a deal that values the fertiliser maker at £404. 9m.
Fevertree loses its fizz after profit warning
Fevertree shares tumbled on Monday after the posh tonics maker said full-year revenue was set to miss the company’s expectations following "subdued" Christmas trading in the UK, with earnings expected to fall 5% from 2018.
Target Healthcare buys Cheshire development site for £9.7m
Specialist care homes investor Target Healthcare has completed the acquisition of a new development site in Cheshire for £9. 7m, including transaction costs, as it continues to deploy the proceeds from its recent oversubscribed capital raise, it announced on Monday.
Symphony International completes exit from IHH Healthcare investment
Symphony International Holdings has fully exited its investment in IHH Healthcare - one of the largest healthcare providers in the world by market capitalisation, with 15,000 beds across 80 hospitals in 10 countries - it announced on Monday.
Coral Products looks ahead after tough half-year
Plastics specialist Coral Products reported a 7. 2% decline in group sales in its half-year report on Monday, to £12. 14m, as its gross profit fell 8. 7% to £4. 6m.
Mincon buys out Finnish manufacturing partner Lehti
Ireland-based rock drilling engineering company Mincon announced the acquisition of Lehti Group of Finland on Monday, in a bid to further enhance its manufacturing capability in the geotechnical and construction market.
Henry Boot upbeat after tough 2019
Construction and property development company Henry Boot reported “good” strategic progress for 2019 on Monday, against what it described as an uncertain political and economic background, reporting that it added to its future opportunity pipeline and invested further in its workforce during the period.
AstraZeneca clears regulatory hurdles with 'Imfinzi' and 'Lynparza'
AstraZeneca announced on Monday that its ‘Imfinzi’ (durvalumab) and tremelimumab, an anti-CTLA4 antibody and potential new medicine, have both been granted orphan drug designation by the Food and Drug Administration (FDA) in the United States, for the treatment of hepatocellular carcinoma (HCC), which is the most common type of liver cancer.